article Open AccessTop 1% cited
Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins
BMC Cancer · 2018 · Vol. 18(1) · pp. 41–41
Carrie J. Lovitt✉(Griffith University)Todd Shelper(Griffith University)Vicky M. Avery(Griffith University)
Abstract
Collectively, these novel findings reveal resistance mechanisms which may contribute to reduced doxorubicin sensitivity.
Cancer Cells and MetastasisCell Adhesion Molecules ResearchHER2/EGFR in Cancer ResearchDoxorubicinExtracellular matrixMatrigelCancer cellCancer researchCell cultureSurgical oncologyBreast cancerCell growthMedicine
MeSH terms
Breast NeoplasmsCell SurvivalCollagenDoxorubicinDrug CombinationsFemaleHumansLamininProteoglycansSignal TransductionExtracellular Matrix ProteinsCell Culture TechniquesDrug Resistance, NeoplasmCell ProliferationMCF-7 Cells
Funding
- Cancer Therapeutics Cooperative Research Centre
Citations
342
FWCI
14.92
field-weighted impact
References
36
Percentile
99%
vs. same field & year
Citations per year
References
High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array
The Analyst · 2010 · 946 citations
HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment
Breast Cancer Research and Treatment · 2009 · 332 citations
Drug penetration in solid tumours
Nature reviews. Cancer · 2006 · 2,726 citations
Mechanisms and insights into drug resistance in cancer
Frontiers in Pharmacology · 2013 · 653 citations
Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy
Journal of Controlled Release · 2012 · 1,141 citations
Global cancer statistics
CA A Cancer Journal for Clinicians · 2011 · 55,006 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.